Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Mousa

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus InhibitorsMai H A Mousa, Nermin S Ahmed, Kai Schwedtmann, et al.
ACS Omega|August 29, 2019
Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core ScaffoldsAlaa R S Leila, Mai H A Mousa, Efseveia Frakolaki, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 21, 2022
Maternal hemodynamics and neonatal birth weight in pregnancies complicated by gestational diabetes: new insights from novel causal inference analysis modelingA R Anness, A Clark, K Melhuish, et al.
Bioorganic Chemistry|May 28, 2024
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigationsHaytham O Tawfik, Mai H A Mousa, Mohamed Y Zaky, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 24, 2015
Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13A T Papageorghiou, A Khalil, M Forman, et al.
Bioorganic Chemistry|September 27, 2024
Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl)thio)acetamide candidates as telomerase/JAK1/STAT3/TLR4 inhibitors: In vitro and in vivo investigationsMoataz A Shaldam, Mai H A Mousa, Haytham O Tawfik, et al.
Bioorganic Chemistry|April 8, 2025
Unveiling the potential of xanthines, discovery of potential 7-benzyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione derivatives with antifibrotic activity for liver injuryAbdalla R Mohamed, Hanan H Georgey, Esraa A Aidy, et al.
Journal of Medicinal Chemistry|December 20, 2023
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical AssessmentsAhmed A Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, et al.
Drug Development Research|March 19, 2025
Innovative Multitarget Organoselenium Hybrids With Apoptotic and Anti-Inflammatory Properties Acting as JAK1/STAT3 SuppressorsSaad Shaaban, Aya Yaseen Mahmood Alabdali, Mai H A Mousa, et al.
Drug Development Research|October 7, 2025
Multi-Target Rational Design and Synthesis of Some 2-Quinolinone Antitumor Candidates Downregulating the Expression of EGFR, VEGFR-2, and Telomerase With Apoptotic PotentialEman A E El-Helw, Mai H A Mousa, Eman A Ghareeb, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|April 3, 2021
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus InhibitorsMai H A Mousa, Nermin S Ahmed, Kai Schwedtmann, et al.
ACS Omega|August 29, 2019
Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core ScaffoldsAlaa R S Leila, Mai H A Mousa, Efseveia Frakolaki, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 21, 2022
Maternal hemodynamics and neonatal birth weight in pregnancies complicated by gestational diabetes: new insights from novel causal inference analysis modelingA R Anness, A Clark, K Melhuish, et al.
Bioorganic Chemistry|May 28, 2024
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigationsHaytham O Tawfik, Mai H A Mousa, Mohamed Y Zaky, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 24, 2015
Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13A T Papageorghiou, A Khalil, M Forman, et al.
Bioorganic Chemistry|September 27, 2024
Muti-target rationale design of novel substituted N-phenyl-2-((6-phenylpyridazin-3-yl)thio)acetamide candidates as telomerase/JAK1/STAT3/TLR4 inhibitors: In vitro and in vivo investigationsMoataz A Shaldam, Mai H A Mousa, Haytham O Tawfik, et al.
Bioorganic Chemistry|April 8, 2025
Unveiling the potential of xanthines, discovery of potential 7-benzyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione derivatives with antifibrotic activity for liver injuryAbdalla R Mohamed, Hanan H Georgey, Esraa A Aidy, et al.
Journal of Medicinal Chemistry|December 20, 2023
Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical AssessmentsAhmed A Al-Karmalawy, Mai H A Mousa, Marwa Sharaky, et al.
Drug Development Research|March 19, 2025
Innovative Multitarget Organoselenium Hybrids With Apoptotic and Anti-Inflammatory Properties Acting as JAK1/STAT3 SuppressorsSaad Shaaban, Aya Yaseen Mahmood Alabdali, Mai H A Mousa, et al.
Drug Development Research|October 7, 2025
Multi-Target Rational Design and Synthesis of Some 2-Quinolinone Antitumor Candidates Downregulating the Expression of EGFR, VEGFR-2, and Telomerase With Apoptotic PotentialEman A E El-Helw, Mai H A Mousa, Eman A Ghareeb, et al.
Pageof 5